in

Dr Reddy’s Unit Ties Up With Shanghai Henlius Biotech

As part of the tie-up, Henlius will be responsible for development, manufacturing and commercial supply, and may receive up to a total of $131.6 million, including an upfront payment of $33 million and milestone payments, Dr Reddy’s Laboratories said in a statement.

Read More

What do you think?

Written by pulseadmin

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Indices: Stock market update: Nifty Realty index falls 2.19%

West Bengal Investment Summit Attracts Rs 4.40 Lakh Crore Investment Proposals: Mamata